Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Rupprecht

Showing results (61-70 of 236) with videos related to

Pageof 24
Sort By:
Plos One|August 22, 2009
Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptorsGerhard Rammes, Christine Hosp, Brigitte Eisensamer, et al.
Psychoneuroendocrinology|February 8, 2005
The combined T3/TRH test in depressed patients and healthy controlsCornelius Schüle, Thomas C Baghai, Vassiliki Tsikolata, et al.
Psychopharmacology|June 8, 2006
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patientsCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Neural Plasticity|July 4, 2014
Structural brain changes following left temporal low-frequency rTMS in patients with subjective tinnitusAstrid Lehner, Berthold Langguth, Timm B Poeppl, et al.
Plos One|January 30, 2009
The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
The American Journal of Psychiatry|January 5, 2002
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatmentAndreas Ströhle, Elena Romeo, Flavia di Michele, et al.
Frontiers in Psychiatry|August 2, 2021
Computer-Assisted Avatar-Based Treatment for Dysfunctional Beliefs in Depressive Inpatients: A Pilot StudyMartin Kocur, Martin Dechant, Christian Wolff, et al.
Neuropharmacology|January 20, 2016
Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signallingSascha Tanasic, Corinna Mattusch, Eva Maria Wagner, et al.
Social Cognitive and Affective Neuroscience|December 28, 2017
Relating experimentally-induced fear to pre-existing phobic fear in the human brainSeth M Levine, Michael Pfaller, Jonas Reichenberger, et al.
Psychoneuroendocrinology|April 8, 2019
Differential effects of TSPO ligands on mitochondrial function in mouse microglia cellsStefanie Bader, Luisa Wolf, Vladimir M Milenkovic, et al.
Pageof 24

Showing results (61-70 of 236) with videos related to

Sort By:
Pageof 24
Plos One|August 22, 2009
Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptorsGerhard Rammes, Christine Hosp, Brigitte Eisensamer, et al.
Psychoneuroendocrinology|February 8, 2005
The combined T3/TRH test in depressed patients and healthy controlsCornelius Schüle, Thomas C Baghai, Vassiliki Tsikolata, et al.
Psychopharmacology|June 8, 2006
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patientsCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Neural Plasticity|July 4, 2014
Structural brain changes following left temporal low-frequency rTMS in patients with subjective tinnitusAstrid Lehner, Berthold Langguth, Timm B Poeppl, et al.
Plos One|January 30, 2009
The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
The American Journal of Psychiatry|January 5, 2002
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatmentAndreas Ströhle, Elena Romeo, Flavia di Michele, et al.
Frontiers in Psychiatry|August 2, 2021
Computer-Assisted Avatar-Based Treatment for Dysfunctional Beliefs in Depressive Inpatients: A Pilot StudyMartin Kocur, Martin Dechant, Christian Wolff, et al.
Neuropharmacology|January 20, 2016
Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signallingSascha Tanasic, Corinna Mattusch, Eva Maria Wagner, et al.
Social Cognitive and Affective Neuroscience|December 28, 2017
Relating experimentally-induced fear to pre-existing phobic fear in the human brainSeth M Levine, Michael Pfaller, Jonas Reichenberger, et al.
Psychoneuroendocrinology|April 8, 2019
Differential effects of TSPO ligands on mitochondrial function in mouse microglia cellsStefanie Bader, Luisa Wolf, Vladimir M Milenkovic, et al.
Pageof 24